ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Breast Cancer
Endometrial Cancer

Prostate Cancer trials near Berlin, BE, DEU:

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

pelvic lymph node metastases in newly-diagnosed adult patients with prostate cancer and an intermediate to high risk for lymph node...

Active, not recruiting
Prostate Cancer
Prostatectomy
Drug: Ferrotran® (Ferumoxtran-10)

Phase 3

Saving Patients' Lives Medical

Berlin, Germany and 14 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Berlin, Germany and 388 other locations

survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate Cancer Wo...

Active, not recruiting
Hormone-Sensitive Prostate Cancer
Drug: Capivasertib
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 322 other locations

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...

Enrolling
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 3

Bayer
Bayer

Berlin, Germany and 302 other locations

hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...

Active, not recruiting
Metastatic Prostate Cancer
Prostate Adenocarcinoma
Drug: Cabozantinib
Drug: Abiraterone Acetate

Phase 3

Exelixis
Exelixis

Berlin, Germany and 278 other locations

vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to ...

Enrolling
Oligometastatic Prostate Cancer (OMPC)
Drug: AAA617

Phase 3

Novartis
Novartis

Berlin, Germany and 102 other locations

Locations recently updated

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA...

Enrolling
Metastatic Castration-Sensitive Prostate Cancer
Drug: Abiraterone Acetate
Drug: Darolutamide

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 407 other locations

The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination...

Active, not recruiting
Prostate Cancer
Drug: Placebo plus enzalutamide
Drug: talazoparib plus enzalutamide

Phase 3

Pfizer
Pfizer

Berlin, Germany and 320 other locations

The purpose of this clinical phase 3 randomized trial is to compare two different dosing schedules of Docetaxel in combination with ADT and Darolutam...

Active, not recruiting
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Drug: Standard Darolutamide
Drug: Standard ADT (androgen deprivation therapy)

Phase 3

Jena University Hospital

Berlin, Germany and 42 other locations

The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer....

Active, not recruiting
Nonmetastatic Castration-Resistant Prostate Cancer
Prostate Cancer
Drug: Placebo
Drug: Enzalutamide

Phase 3

Pfizer
Pfizer

Berlin, Germany and 396 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems